Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Effect of Bivalirudin on Aortic Valve Intervention Outcomes 2/3 (BRAVO 2/3)

Next Previous
X
Search
Trial Profile

Effect of Bivalirudin on Aortic Valve Intervention Outcomes 2/3 (BRAVO 2/3)

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 25 Jul 2022

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Bivalirudin (Primary) ; Heparin
  • Indications Thrombosis
  • Focus Adverse reactions; Registrational
  • Acronyms BRAVO 2/3; BRAVO-3
  • Sponsors The Medicines Company

    • Most Recent Events

    • 04 Apr 2022 Results assessing the effect of CAD on clinical outcomes following TAVR and the interaction between CAD and different periprocedural anticoagulant, presented at the 71st Annual Scientific Session of the American College of Cardiology.
    • 04 Apr 2022 Results assessing the effect of Chronic Thrombocytopenia on clinical outcomes presented at the 71st Annual Scientific Session of the American College of Cardiology
    • 15 Nov 2021 Results of subgroup analysis assessing Impact of anemia on short-term outcomes after Impact of anemia on short-term outcomes after transcatheter aortic valve replacement (TAVR) published in the Catheterization and Cardiovascular Interventions

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top